Ad is loading...
CRSP
Price
$47.25
Change
+$0.40 (+0.85%)
Updated
Nov 15 closing price
93 days until earnings call
SGMT
Price
$4.73
Change
-$0.45 (-8.69%)
Updated
Nov 15 closing price
Ad is loading...

CRSP vs SGMT

Header iconCRSP vs SGMT Comparison
Open Charts CRSP vs SGMTBanner chart's image
CRISPR Therapeutics AG
Price$47.25
Change+$0.40 (+0.85%)
Volume$3.13M
CapitalizationN/A
Sagimet Biosciences
Price$4.73
Change-$0.45 (-8.69%)
Volume$837.49K
CapitalizationN/A
CRSP vs SGMT Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRSP vs. SGMT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongSell and SGMT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CRSP: $47.25 vs. SGMT: $4.73)
Brand notoriety: CRSP and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 234% vs. SGMT: 47%
Market capitalization -- CRSP: $4.03B vs. SGMT: $152.28M
CRSP [@Biotechnology] is valued at $4.03B. SGMT’s [@Biotechnology] market capitalization is $152.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while SGMT’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • SGMT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CRSP and SGMT are a bad buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а -8.47% price change this week, while SGMT (@Biotechnology) price change was -20.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

SGMT is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.03B) has a higher market cap than SGMT($152M). SGMT YTD gains are higher at: -12.731 vs. CRSP (-24.521). SGMT has higher annual earnings (EBITDA): -36.28M vs. CRSP (-335.17M). CRSP has more cash in the bank: 484M vs. SGMT (166M). SGMT has less debt than CRSP: SGMT (153K) vs CRSP (231M). CRSP has higher revenues than SGMT: CRSP (200M) vs SGMT (2M).
CRSPSGMTCRSP / SGMT
Capitalization4.03B152M2,653%
EBITDA-335.17M-36.28M924%
Gain YTD-24.521-12.731193%
P/E RatioN/AN/A-
Revenue200M2M10,000%
Total Cash484M166M292%
Total Debt231M153K150,980%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
74
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPSGMT
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FACVX36.14-0.10
-0.28%
Fidelity Advisor Convertible Secs A
FSEPX13.20-0.15
-1.12%
Fidelity Advisor Sustainable U.S. Eq M
FCPGX34.48-0.59
-1.68%
Fidelity Small Cap Growth
AGGDX12.90-0.22
-1.68%
American Century Focused Global Gr R6
GSTRX9.91-0.23
-2.27%
Goldman Sachs Strategic Growth R

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+0.85%
BEAM - CRSP
75%
Closely correlated
-8.59%
EDIT - CRSP
64%
Loosely correlated
-3.97%
NTLA - CRSP
63%
Loosely correlated
-7.61%
PRME - CRSP
59%
Loosely correlated
-6.95%
RXRX - CRSP
56%
Loosely correlated
-10.64%
More

SGMT and

Correlation & Price change

A.I.dvisor tells us that SGMT and CRSP have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGMT and CRSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-8.69%
CRSP - SGMT
33%
Poorly correlated
+0.85%
PLRX - SGMT
31%
Poorly correlated
-3.27%
ALLO - SGMT
30%
Poorly correlated
-7.72%
ETNB - SGMT
29%
Poorly correlated
-9.37%
BEAM - SGMT
28%
Poorly correlated
-8.59%
More